Founded in Toronto in 2015, NuraLogix Corporation has emerged as a trailblazer in Affective AI—a revolutionary field that uses artificial intelligence to interpret facial blood flow and extract real-time health insights from a simple 30-second video selfie. At the heart of this innovation lies DeepAffex™, the company’s proprietary engine powered by patented Transdermal Optical Imaging (TOI™) technology. This platform analyzes more than 100 physiological, metabolic, and psychological parameters—including heart rate, blood pressure, stress levels, type-2 diabetes risk, and even signs of fatty liver disease—using nothing more than a video feed from a smartphone, desktop, smart mirror, or public kiosk.
Their flagship product, Anura®, comes in both consumer and enterprise formats. It’s accessible across mobile apps, web platforms, SDKs, desktop solutions, and the cutting-edge Anura® MagicMirror, a smart mirror that enables contactless vital sign monitoring in clinics, corporate wellness centers, and community health booths. Building further, Anura® Telehealth integrates seamlessly with platforms like Zoom and Microsoft Teams to deliver live, continuous health monitoring during virtual consultations.
Today, NuraLogix serves a rapidly growing user base of over 200,000 mobile users and more than 50 enterprise clients worldwide. With 13 international patents and validation through peer-reviewed clinical studies, the company is setting new standards for medical-grade, sensor-free health diagnostics—accessible, scalable, and non-invasive.
In an exclusive interaction with The Interview World at India Health 2025, Sanjay K Bhardwaj, Director of Sales (India), offers a deep dive into how NuraLogix is redefining self-managed healthcare through intelligent, tech-driven solutions. He discusses the company’s unique business model, sheds light on the diagnostic precision of their platform, emphasizes accessibility and affordability, and outlines a bold vision for long-term growth and global expansion.
Here are the most compelling takeaways from that conversation.
Q: Could you provide an overview of NuraLogix Corporation’s key healthcare solutions and the specific needs they address within the industry?
A: NuraLogix, headquartered in Toronto, Canada, has pioneered a breakthrough technology known as Transdermal Optical Imaging (TOI™). This innovation marks a paradigm shift in how individuals engage with their health—placing the power of real-time wellness monitoring directly into their hands.
Through Anura®, NuraLogix’s mobile application, users can independently track key health metrics using just a smartphone. A simple 30-second video selfie generates over 30 clinical-grade results instantly, offering a comprehensive snapshot of the user’s physical and psychological wellbeing. The app culminates in an overall wellness score, rated on a scale of 1 to 100, giving users a clear, data-driven picture of their current health status.
Crucially, the platform goes beyond self-monitoring. If a user is connected to a healthcare provider and the system detects abnormal readings—whether elevated or critically low—an automatic alert is sent to the doctor in real-time. This enables immediate virtual intervention, allowing clinicians to address potential complications before they escalate.
In effect, NuraLogix delivers a fully digital, proactive care solution—empowering both patients and healthcare professionals to take timely, informed actions. It eliminates the need for hospital visits in many cases, dramatically improving access, efficiency, and outcomes in everyday health management.
Q: What is your go-to-market strategy for this application—are you positioning it as a B2B, B2C, or hybrid model for reaching end users?
A: Healthcare has traditionally been driven by doctors and medical professionals. At NuraLogix, we position ourselves as an integral extension of their care teams—not a replacement, but a powerful enabler.
We deliver curated, cutting-edge technology designed specifically for clinicians, empowering them to extend better, more consistent care to patients who require continuous monitoring. This not only improves patient outcomes but also helps significantly reduce hospital visits and associated costs.
Our collaborations span across hospitals, chronic care centers, and government health institutions. Currently, we are also engaging with the Government of India to support nationwide screening and preventive care initiatives. The goal is clear: to take affordable, accessible healthcare to the last mile—reaching underserved populations that remain untouched by modern medical advancements.
Through this effort, we aim to make early detection and proactive care the new norm—minimizing medical expenses while maximizing health equity across the population.
Q: How does the diagnostic accuracy of Anura compare with traditional clinical methods, and what validations or studies support its reliability?
A: Before launching our technology commercially, we rigorously validated the concept through extensive global testing. We conducted a series of structured trials across multiple universities, institutions, and regulatory bodies worldwide. These included multi-centric studies spanning diverse geographies, demographics, and health profiles to ensure the consistency and reliability of our results.
When it comes to accuracy, the results speak for themselves. For physiological parameters such as heart rate and blood pressure, our platform consistently achieves an accuracy rate of around 94%. For blood-based markers, including metabolic indicators, the current accuracy stands at approximately 85–86%.
However, this is just the beginning. As our data pool expands and our algorithms continue to learn and refine, we expect these figures to move steadily closer to 100%—if not reach it entirely—in the near future.
Q: How accessible and affordable is this technology for patients?
A: We’ve designed our pricing to make advanced health monitoring as affordable as a monthly cup of coffee. For just ₹100 per user per month, patients can access unlimited scans using our platform.
This cost—comparable to a single glucose test or a routine coffee purchase—makes our solution extraordinarily accessible. By removing price as a barrier, we empower users to monitor their health proactively without financial strain. It’s comprehensive wellness at a price point that fits seamlessly into everyday life.
Q: What is your long-term vision for NuraLogix’s growth and expansion?
A: We have several promising business opportunities unfolding in India—across government bodies, private sector players, and insurance providers. Momentum is building quickly, and we’ve already gained significant traction among key stakeholders, both within India and internationally.
Looking ahead, we are confident that adoption will accelerate at scale, particularly as more institutions recognize the value of our technology in delivering affordable, high-impact healthcare solutions. With broader integration, we aim to empower patients, reduce costs, and help ensure better health outcomes across the board.
Q: Given your mention of the insurance sector as a potential major end user, how do you envision this technology transforming or adding value to that industry?
A: Globally, insurance remains our most strategic partner. We collaborate with some of the world’s largest insurance providers—including Bupa, AIA, and AIG—who rely on our technology to enhance preventive care and customer engagement. Without question, insurance forms our largest client base worldwide.
However, our reach extends far beyond. We actively work with hospitals, healthcare providers, chronic care management companies, elderly care facilities, and even players in the automotive and consumer goods sectors. This multi-vertical presence has enabled us to establish a robust footprint across both India and global markets.
Today, we proudly operate in 37 countries, serving over 200 enterprise clients. Many of these clients deploy our solutions across multiple regions, reflecting the scalability and versatility of our platform. Our global network continues to grow, underpinned by a strong foundation of trust, innovation, and measurable impact.
